Re: What H1N1 (Govt. declared) Emergency???
Posted by:
Tamukha
()
Date: April 01, 2010 07:46PM I heard this on the radio this morning and just thought, "Not this again . . . "
I guess someone needs to recoup their market share. [sigh] Re: What H1N1 (Govt. declared) Emergency???
Posted by:
riverhousebill
()
Date: April 01, 2010 08:32PM This time it looks like they might need a real virus in order to sell a trial vaccine, sorry Donald better scare next time. Re: What H1N1 (Govt. declared) Emergency???
Posted by:
tropical
()
Date: April 14, 2010 01:10PM At least he was ethical and didn't release something really scary, like smallpox. Also, do you think they might credit the vaccination campaign with the non-epidemic? About half the people I know got vaccinated. Re: What H1N1 (Govt. declared) Emergency???
Posted by:
juicerkatz
()
Date: April 14, 2010 04:39PM tropical Wrote:
------------------------------------------------------- > At least he was ethical and didn't release > something really scary, like smallpox. Also, do > you think they might credit the vaccination > campaign with the non-epidemic? About half the > people I know got vaccinated. They can spin it anyway they need to... Re: What H1N1 (Govt. declared) Emergency???
Posted by:
riverhousebill
()
Date: April 16, 2010 09:29PM Low vax demand could threaten H1N1 profits
Related Stories Sanofi recalls pediatric H1N1 shots Flu-remedy news spreads along with virus Israel wants flu vax made at home Swine flu could be FluMist's moment GSK allows Brits to cut H1N1 vax order by one-third Some European customers are negotiating to return millions of unused doses of H1N1 vaccine to four suppliers, threatening the companies' huge revenue boost from the global pandemic. Apparently, governments had expected people to turn out in big numbers for the shot, but that isn't happening--and so the buyers want their money back. Analysts estimate that sales of flu shots from GlaxoSmithKline, Sanofi-Aventis, Novartis and AstraZeneca could be 15 percent lower than initially thought. In GlaxoSmithKline's case, that would amount to a £330 million ($534 million) reduction. The company had collected enough vaccine orders to boost its 2009 revenues up by £1 billion ($1.6 billion), and that total was expected to grow to £2.2 billion ($3.5 billion) over the course of the pandemic. Sales boosts for the other companies had been expected to be smaller, with Sanofi predicted to gain €750 million ($1.07 billion) and Novartis €600 million ($860 million), so at a 15 percent reduction, they'd lose commensurately less. Only 20 percent of the high-risk groups in Spain showed up for the vaccine; that country had ordered 14.7 million doses. Meanwhile, in Germany, which ordered 50 million doses, officials believe people will need only one dose apiece rather than two, so they're looking to cut back on that order. Spanish officials say they've made headway in getting the companies to take back the unneeded shots: "The contracts ... included clauses which allow the return of unused vaccines so they can be distributed to other countries," Health Minister Trinidad Jiminez told reporters. And a Glaxo spokesman told the Mail that the company "continue Read more: [www.fiercepharma.com] Re: What H1N1 (Govt. declared) Emergency???
Posted by:
Jgunn
()
Date: April 17, 2010 09:06PM hehe the pandemic that never was ...Jodi, the banana eating buddhist Re: What H1N1 (Govt. declared) Emergency???
Posted by:
Anonymous User
()
Date: April 18, 2010 02:50AM Jgunn Wrote:
------------------------------------------------------- > hehe the pandemic that never was Again. Sorry, only registered users may post in this forum.
|
|